chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea
Clinical narrative: Nauseous; Headache; Chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 29Apr2021 (Lot number: EW0172) at the age of 73 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Covid", start date: Jan2021 (unspecified if ongoing), notes: Verbatim: I had Covid in January and was in the hospital from the 20th to the 27th. Concomitant medication(s) included: PRILOSEC [OMEPRAZOLE MAGNESIUM]. The following information was reported: NAUSEA (non-serious), outcome "unknown", described as "Nauseous"; HEADACHE (non-serious), outcome "unknown", described as "Headache"; CHILLS (non-serious), outcome "unknown", described as "Chills". Therapeutic measures were not taken as a result of nausea, headache, chills.  Additional information: Consumer stated the concern, "I just have a question I don't know whether u can help me or not but I have my first Pfizer vaccine yesterday and I had Covid in January and was in the hospital from the 20th to the 27th, now some of the symptom that I am feeling today after having shot yesterday is I just feel very nauseous, I have a headache and chills, now is that, do the symptom seems to be worse if you had Covid before or I know this will be worse after 2nd shot , bit my concern is that its pretty bad this time so do they, is that because of I had Covid in the past."  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Dizziness, Influenza like illness
Clinical narrative: I did feel light headed but those were the worst thing; I feel like I have the flu; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old male patient received bnt162b2 (BNT162B2), administered in deltoid right, administration date 02Apr2021 (Lot number: EP7533) at the age of 39 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 2021, outcome "unknown", described as "I did feel light headed but those were the worst thing"; INFLUENZA LIKE ILLNESS (non-serious) with onset 2021, outcome "unknown", described as "I feel like I have the flu". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Consumer stated,  feel like I have the flu and I am surprised how is my fever been. After my first vaccination I felt like I was starting to come done with something the morning after but that was about the extent of it, I did feel light headed but those were the worst thing, the light headed and the next day felt like I was coming down with something but it never got bad. Patient underwent blood test on an unspecified date. I may have some immune condition but is not established yet but I have done blood work and I may have some autoimmune issues. There is evidence on my blood work but it is not diagnosed yet.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Vomiting
Clinical narrative: She violently was throwing up, had severe diarrhea and severe vomiting's for 3 days.; She violently was throwing up, had severe diarrhea and severe vomiting's for 3 days.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 22 year-old female patient received bnt162b2 (BNT162B2) (Lot number: ER8729) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIARRHOEA (non-serious), VOMITING (non-serious), outcome "unknown" and all described as "She violently was throwing up, had severe diarrhea and severe vomiting's for 3 days".  Additional information: Patient received the vaccine, the Pfizer vaccine. Patient was 22 years old, had it about Friday morning and on Sunday afternoon patient violently was throwing up, had severe diarrhea and severe vomiting's for 3 days.   No follow-up attempts are possible. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: locked up my shoulder/pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old female patient received bnt162b2 (BNT162B2), administered in deltoid right, administration date 25Feb2021 (Lot number: EN6198) at the age of 73 years as dose 1, single and administration date 18Mar2021 (Lot number: EN6208) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Heart Problem" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "Depression" (unspecified if ongoing); "several glands removed along the breast area" (unspecified if ongoing), notes: because they were enlarged. Concomitant medication(s) included: ELIQUIS; METOPROLOL TARTRATE taken for hypertension; WELLBUTRIN SR taken for depression; LANSOPRAZOLE. The following information was reported: ARTHRALGIA (non-serious), outcome "unknown", described as "locked up my shoulder/pain". Therapeutic measures were taken as a result of arthralgia.  Additional information: patient had an adverse reaction to COVID -19 vaccine: it landed on the side where several glands removed along the breast area because they were enlarged, it settled right there in that area and locked up her shoulder and when she got the second one she could not move the arm. She had got to see a chiropractor and go back to her orthopedist to get cortisone shot and a step for physical therapy which she has been doing and she was finally home and she was continuing here at home but it messed me up. Patient cannot lie on her left side and it hurt so much to move it but she was pushing through. She was losing control of her shoulder. Patient had swollen lymph nodes alongside of my breast which were removed, that was before taking the vaccine. She got about 75 percent use that she had to continue with the therapy and make it for function. Patient was told or she may have to have surgery. Treatment: shoulder freeze. Patient went to a chiropractor to break up the calcium deposits cannot use it and she went to the orthopedist to get cortisone injection in shoulder.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021504971 same reporter/drug, different patient/ event
Sex: M
Vaccine: COVID19
Symptoms: Sedation
Clinical narrative: Felt a little dragged out; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Covid-19", start date: Nov2020 (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number : 1), for Covid-19 immunization. The following information was reported: SEDATION (non-serious), outcome "recovered", described as "Felt a little dragged out".  Additional Information: It was reported that the second one when the patient went for that shot, he said he felt a little dragged out, laid down for a while, was fine, and went to work. It did not effect him even though he had COVID, but he had a mild case of COVID in November. It was very mild because he got positive test of COVID, but was at work the following day. He needed to go for testing due to work.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Got the Pfizer. Tired; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team.  An 85-year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as single dose for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "Got the Pfizer. Tired". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Headache, Pain, Scan brain
Clinical narrative: Pain; headache was so painful; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56 year-old female patient received bnt162b2 (BNT162B2) (Lot number: EW0153) as dose 1, single for covid-19 immunisation. Relevant medical history included: "headache" (unspecified if ongoing), notes: same headache I had 14 years and then never had it again. Concomitant medication(s) included: ADVIL [IBUPROFEN]. The following information was reported: PAIN (non-serious), outcome "not recovered", described as "Pain"; HEADACHE (non-serious), outcome "not recovered", described as "headache was so painful". The events "pain" and "headache was so painful" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain, headache.  Additional Information: Consumer reported that she had to go to the ER. They didn't find anything with the headache, but the headache was so painful. Years ago, she had a brain scan and some blood work. Reporter received Tylenol at Hospital.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Energy increased, Fatigue
Clinical narrative: on the 2nd felt very tired had lots of rest; I even feel more energetic; This is a spontaneous report received from a non-contactable reporter (Consumer) for a sponsored program. The reporter is the patient.  A female patient received BNT162B2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.Vaccination history included: BNT162B2 (Dose 1, Single, (Lot # not provided)), for COVID-19 immunization, reaction(s): "Headache", "Minor sore on the short area". The following information was reported: FATIGUE (non-serious) with onset Apr2021, outcome "recovered", described as "on the 2nd felt very tired had lots of rest"; ENERGY INCREASED (non-serious) with onset Apr2021, outcome "unknown", described as "I even feel more energetic".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021492901 same patient and drug; different event and dose
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: minor sore on the shot area; headache; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "minor sore on the shot area"; HEADACHE (non-serious), outcome "unknown", described as "headache". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: sore arm; tiredness; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Apr2021, outcome "unknown", described as "sore arm"; FATIGUE (non-serious) with onset Apr2021, outcome "unknown", described as "tiredness".  Additional information: Patient received the first dose the week before.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: small headache; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 29Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 29Apr2021, outcome "recovered", described as "small headache".  Additional Information: Two hours after vaccination, patient had small headache. It was reported that patient will be fully vaccinated on 04Jun2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Blepharospasm, Conjunctivitis, Lacrimation increased
Clinical narrative: Right eye twitching; Eyes were watery; left eye had conjunctivitis like symptoms; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Mar2021 09:00 (Lot number: EN6208) at the age of 40 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hashimotos" (unspecified if ongoing), notes: Hashimotos, I have had autoimmune reactions affect my eyes for the past few years; "Hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID. Past drug history included: Percocet, reaction(s): "known allergies: Percocet", notes: known allergies: Percocet; Zyrtec, reaction(s): "known allergies: Zyrtec", notes: known allergies: Zyrtec; Augmentin, reaction(s): "known allergies: Augmentin", notes: known allergies: Augmentin. The following information was reported: BLEPHAROSPASM (non-serious) with onset 29Mar2021 12:00, outcome "recovering", described as "Right eye twitching"; LACRIMATION INCREASED (non-serious) with onset 29Mar2021 12:00, outcome "recovering", described as "Eyes were watery"; CONJUNCTIVITIS (non-serious) with onset 29Mar2021 12:00, outcome "recovering", described as "left eye had conjunctivitis like symptoms". Therapeutic measures were not taken as a result of blepharospasm, lacrimation increased, conjunctivitis. Additional information: Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient didn't have this onset of symptoms before getting the vaccine. The patient had autoimmune reactions affecting eyes for the past few years, so this may be similar response to a foreign substance. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Hypomania
Clinical narrative: Hypomanic for 2 hours; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient received bnt162b2 (BNT162B2), administered in arm left (Lot number: er8737) as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19: Yes; "Rheumatoid arthritis" (unspecified if ongoing); "drug allergy with beta blocker medication" (unspecified if ongoing). There were no concomitant medications. The following information was reported: HYPOMANIA (non-serious), outcome "recovered", described as "Hypomanic for 2 hours".  Additional Information: It was reported that prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. the patient experienced hypomanic for 2 hours. The patient had uncontrolled rheumatoid arthritis and thought it was cured. All rheumatoid arthritis symptoms gone but patient was told Hypomanic.  No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Rash macular, Vaccination site erythema
Clinical narrative: Mild headache; experiencing redness in the injection site; Chills really bad; Felt like truck hit me; My arm has red blotches, rash and pain on injection site; it's terrible; My arm has red blotches, rash and pain on injection site; it's terrible; My arm has red blotches, rash and pain on injection site; it's terrible; This is a spontaneous report received from a contactable Consumer for a Pfizer sponsored program (159558). The reporter is the patient.  A 57 year-old female patient received bnt162b2 (BNT162B2), administered in arm, administration date 30Apr2021 01:00 (Batch/Lot number: unknown) at the age of 57 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Bnt162b2 (1st dose), administration date: 09Apr2021, when the patient was 57 years old, for Covid-19 immunization, reaction(s): "I did go nothing". The following information was reported: CHILLS (non-serious) with onset 01May2021 03:00, outcome "unknown", described as "Chills really bad"; FEELING ABNORMAL (non-serious) with onset 01May2021 03:00, outcome "unknown", described as "Felt like truck hit me"; HEADACHE (non-serious), outcome "unknown", described as "Mild headache"; RASH MACULAR (non-serious), VACCINATION SITE RASH (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 01May2021 03:00, outcome "unknown" and all described as "My arm has red blotches, rash and pain on injection site; it's terrible"; VACCINATION SITE ERYTHEMA (non-serious), outcome "unknown", described as "experiencing redness in the injection site". Therapeutic measures were taken as a result of chills, feeling abnormal, headache, rash macular, vaccination site rash, vaccination site pain with Ibuprofen.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: Mild headache; experiencing redness in the injection site; Chills really bad; Felt like truck hit me; My arm has red blotches, rash and pain on injection site; it's terrible; My arm has red blotches, rash and pain on injection site; it's terrible; My arm has red blotches, rash and pain on injection site; it's terrible; This is a spontaneous report received from a contactable Consumer for a Pfizer sponsored program (159558). The reporter is the patient.  A 57 year-old female patient received bnt162b2 (BNT162B2), administered in arm, administration date 30Apr2021 01:00 (Batch/Lot number: unknown) at the age of 57 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Bnt162b2 (1st dose), administration date: 09Apr2021, when the patient was 57 years old, for Covid-19 immunization, reaction(s): "I did go nothing". The following information was reported: CHILLS (non-serious) with onset 01May2021 03:00, outcome "unknown", described as "Chills really bad"; FEELING ABNORMAL (non-serious) with onset 01May2021 03:00, outcome "unknown", described as "Felt like truck hit me"; HEADACHE (non-serious), outcome "unknown", described as "Mild headache"; RASH MACULAR (non-serious), VACCINATION SITE RASH (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 01May2021 03:00, outcome "unknown" and all described as "My arm has red blotches, rash and pain on injection site; it's terrible"; VACCINATION SITE ERYTHEMA (non-serious), outcome "unknown", described as "experiencing redness in the injection site". Therapeutic measures were taken as a result of chills, feeling abnormal, headache, rash macular, vaccination site rash, vaccination site pain with Ibuprofen.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Energy increased, Insomnia
Clinical narrative: feeling "racey" (a lot of energy); trouble sleeping; This is a spontaneous report received from a non-contactable consumer for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 23Apr2021 (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (dose 1, Batch/Lot number: unknown), for COVID-19 immunisation. The following information was reported: ENERGY INCREASED (non-serious) with onset Apr2021, outcome "unknown", described as "feeling "racey" (a lot of energy)"; INSOMNIA (non-serious) with onset Apr2021, outcome "unknown", described as "trouble sleeping".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia
Clinical narrative: she has an ongoing headache; has been struggling with insomnia; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 61 year-old female patient received bnt162b2 (BNT162B2), administration date 19Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "not recovered", described as "she has an ongoing headache"; INSOMNIA (non-serious), outcome "not recovered", described as "has been struggling with insomnia".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure abnormal, Blood pressure measurement, Dizziness
Clinical narrative: weakness; Light-headed/Dizziness; blood pressure 73/56; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 27Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ASTHENIA (non-serious) with onset 27Mar2021, outcome "unknown", described as "weakness"; DIZZINESS (non-serious) with onset 27Mar2021, outcome "unknown", described as "Light-headed/Dizziness"; BLOOD PRESSURE ABNORMAL (non-serious) with onset 27Mar2021, outcome "unknown", described as "blood pressure 73/56". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Caller reports that she got home and thought it would go away but reported I noticed it was not going away and that she was feeling both dizziness and weakness. Caller reported that she read on the fact sheet that dizziness can be experienced but she also noticed that her blood pressure was really low (73/56) and she asks, is low blood pressure a side effect and if not what was the cause of the dizziness that people experienced as the side effect. Last Tuesday Patient had got her first dose and everything was okay, her arm was fine, Patient was sitting and playing with her device and had 4 minutes left till it was time to go from the vaccination facility and patient felt lightheaded, they put her down and recovered. She has blood pressure monitor, she was checking her Blood pressure it was 73/56. She usually has a low pulse because she is a runner and even her Hear rate is usually like 56 or 54 so she was not concerned by that but she was wit her pressure 73/56, that was next day on Wednesday. Yesterday Sunday her pressure was 85 or something over 65. This morning 88 over something. She had her morning coffee and that always helps to boost her pressure, it went over 90 over something. Her pressure is climbing up slowly, but she cannot do her work outs.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Constipation
Clinical narrative: constipated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 29Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose.), administration date: 07Apr2021, for COVID-19 Immunization. The following information was reported: CONSTIPATION (non-serious) with onset Apr2021, outcome "unknown", described as "constipated".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Constipation
Clinical narrative: she's been very constipated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 29Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE), administration date: 07Apr2021, for COVID-19 immunization. The following information was reported: CONSTIPATION (non-serious) with onset 2021, outcome "unknown", described as "she's been very constipated".  Reported verbatim: Patient asked if she could take Miralax for constipation. The patient mentioned that Miralax contains polyethylene glycol that was also one of the ingredients of the vaccine. She already got her 2nd dose last 29Apr2021 and got her 1st dose last 07Apr2021. She had been very constipated. Some unaddressed medical questions were referred or forwarded to Medical Information.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Caller stated she's still hurting from the first shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2), administration date 30Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset 2021, outcome "not recovered", described as "Caller stated she's still hurting from the first shot". Therapeutic measures were taken as a result of pain.  Additional information: The patient received first dose of Pfizer's COVID vaccine on Friday. The HCP told her not to take ibuprofen right away but she didn't specify how many days after the shot she could start taking it again. The patient was asking when she could start taking ibuprofen. The patient stated that she was still hurting from the first shot and she had been taking Tylenol.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: runny nose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 19Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Family history included: "allergies" (unspecified if ongoing), notes: her Mother and friend had the vaccine and their allergies were acting up. The patient's concomitant medications were not reported. The following information was reported: RHINORRHOEA (non-serious), outcome "unknown", described as "runny nose".  Additional information: Has allergies like runny nose that started last Saturday. Due for 2nd dose the 20th, Also states her Mother and friend had the vaccine and their allergies were acting up. Her mom says her nose was stuffy. Her boyfriend had his arm sore and couldn't move it but was ok the next day.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Bone neoplasm
Clinical narrative: marble-sized lump in clavicle/little lump is painful; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 32 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 32 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BONE NEOPLASM (non-serious), outcome "unknown", described as "marble-sized lump in clavicle/little lump is painful".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder, Myalgia
Clinical narrative: prolonged muscle soreness in left arm/muscle soreness; disruption of menstrual cycle/delay in cycle start; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Mar2021 08:30 (Lot number: ER8737) at the age of 33 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "known allergies:Sulfa" (unspecified if ongoing), notes: known allergies:Sulfa. Concomitant medication(s) included: CLARITIN [LORATADINE]; ALEVE; OLLY WOMENS MULTIVITAMIN. The following information was reported: MYALGIA (non-serious) with onset 2021, outcome "recovered" (2021), described as "prolonged muscle soreness in left arm/muscle soreness"; MENSTRUAL DISORDER (non-serious) with onset 2021, outcome "recovered" (2021), described as "disruption of menstrual cycle/delay in cycle start". Therapeutic measures were not taken as a result of myalgia, menstrual disorder.  Additional Information: The patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any treatment for the events.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Facial pain, Headache, Neck pain, Oropharyngeal pain
Clinical narrative: extreme discomfort up left side of neck and face; extreme discomfort up left side of neck and face; extreme aching teeth; Severe headache; red sore throat; extreme discomfort; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old male patient received bnt162b2 (BNT162B2), administered in arm left (Lot number: ER 8729) at the age of 55 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Type 2 Diabetes" (unspecified if ongoing); "Chronic Inflammation" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN CALCIUM; METFORMIN. Past drug history included: Novocaine, reaction(s): "Allergies: Novocaine". Vaccination history included: Bnt162b2 (Dose 1, single, Lot Number: ER 8737, Administration time: 04:00 PM, Vaccine location: Left arm), administration date: 31Mar2021, when the patient was 55 years old, for COVID-19 immunaisation, reaction(s): "Slight pain", "discomfort up left side of neck and face", "aching teeth". The following information was reported: FACIAL PAIN (non-serious), NECK PAIN (non-serious) all with onset 26Apr2021, outcome "not recovered" and all described as "extreme discomfort up left side of neck and face"; TOOTHACHE (non-serious) with onset 26Apr2021, outcome "not recovered", described as "extreme aching teeth"; HEADACHE (non-serious) with onset 26Apr2021, outcome "not recovered", described as "Severe headache"; OROPHARYNGEAL PAIN (non-serious) with onset 26Apr2021, outcome "not recovered", described as "red sore throat"; DISCOMFORT (non-serious) with onset 26Apr2021, outcome "not recovered", described as "extreme discomfort". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of facial pain, neck pain, toothache, headache, oropharyngeal pain, discomfort.  Additional Information: Facility type vaccine: Pharmacy or Drug Store. No, other vaccine in four weeks. Other medications in two weeks: Atorvastatin, Metformin  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, Toothache
Clinical narrative: extreme discomfort up left side of neck and face; extreme discomfort up left side of neck and face; extreme aching teeth; Severe headache; red sore throat; extreme discomfort; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old male patient received bnt162b2 (BNT162B2), administered in arm left (Lot number: ER 8729) at the age of 55 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Type 2 Diabetes" (unspecified if ongoing); "Chronic Inflammation" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN CALCIUM; METFORMIN. Past drug history included: Novocaine, reaction(s): "Allergies: Novocaine". Vaccination history included: Bnt162b2 (Dose 1, single, Lot Number: ER 8737, Administration time: 04:00 PM, Vaccine location: Left arm), administration date: 31Mar2021, when the patient was 55 years old, for COVID-19 immunaisation, reaction(s): "Slight pain", "discomfort up left side of neck and face", "aching teeth". The following information was reported: FACIAL PAIN (non-serious), NECK PAIN (non-serious) all with onset 26Apr2021, outcome "not recovered" and all described as "extreme discomfort up left side of neck and face"; TOOTHACHE (non-serious) with onset 26Apr2021, outcome "not recovered", described as "extreme aching teeth"; HEADACHE (non-serious) with onset 26Apr2021, outcome "not recovered", described as "Severe headache"; OROPHARYNGEAL PAIN (non-serious) with onset 26Apr2021, outcome "not recovered", described as "red sore throat"; DISCOMFORT (non-serious) with onset 26Apr2021, outcome "not recovered", described as "extreme discomfort". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of facial pain, neck pain, toothache, headache, oropharyngeal pain, discomfort.  Additional Information: Facility type vaccine: Pharmacy or Drug Store. No, other vaccine in four weeks. Other medications in two weeks: Atorvastatin, Metformin  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Nausea
Clinical narrative: Not feeling well experiencing nausea; Not feeling well experiencing nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 08Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), NAUSEA (non-serious) all with onset Apr2021, outcome "unknown" and all described as "Not feeling well experiencing nausea".  Additional information: Patient had his 1st dose of COVID-19 Vaccine (08Apr2021) and 2nd dose will be today (29Apr2021) but he can't make it because the patient was not feeling well experiencing nausea and wanted to reschedule his 2nd dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Tinnitus
Clinical narrative: ringing in the ears; hard to sleep at night; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 16Feb2021 (Batch/Lot number: unknown) at the age of 69 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization. The following information was reported: TINNITUS (non-serious) with onset 2021, outcome "unknown", described as "ringing in the ears"; INSOMNIA (non-serious) with onset 2021, outcome "unknown", described as "hard to sleep at night".  Reported verbatim: Caller wanted to know if anyone had reported ringing in the ears as a side effect from the Pfizer COVID vaccine. She received her second dose of the vaccine on 16Feb2021. It had been three months since receiving the vaccine but four days ago she noticed a ringing in the ears that sounds like a bug was buzzing in her ear. This ringing comes and goes. Because of ringing in ears, it was hard to sleep at night because making louder noises. She had a shot in her right arm. She never had ringing in her ears before. When probed for the LOT, consumer stated, the last shot was Pfizer EN looks like a 6200. It was hand written it's hard to read.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Limb discomfort
Clinical narrative: arm soreness; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 26 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIMB DISCOMFORT (non-serious), outcome "unknown", described as "arm soreness"; FATIGUE (non-serious), outcome "unknown", described as "fatigue".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort
Clinical narrative: Digetive symptoms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A male patient received bnt162b2 (BNT162B2), administration date 12Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ABDOMINAL DISCOMFORT (non-serious), outcome "unknown", described as "Digetive symptoms".  Additional information: Reporter got the shot with her son and daughter who both also had digestive symptoms.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: patient just felt terrible and reporter said well if you get to feeling any worse; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from Pfizer Program.  A female patient received bnt162b2 (BNT162B2, Solution for injection) (Batch/Lot number: unknown) as DOSE NUMBER UNKNOWN, SINGLE dose for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "patient just felt terrible and reporter said well if you get to feeling any worse".  Additional information: The reporter consider that the causality of the event was related to suspect product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Paraesthesia
Clinical narrative: Sour tinge in mouth; Tingling arms or fingers; This is a spontaneous report received from a contactable consumer from medical information team. The reporter is the patient.  A 36-year-old female patient received BNT162B2 (BNT162B2) (Batch/Lot number: unknown) at the age of 36 years as dose 1, single for COVID-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DYSGEUSIA (non-serious), outcome "unknown", described as "Sour tinge in mouth"; PARAESTHESIA (non-serious), outcome "unknown", described as "Tingling arms or fingers".  Additional Information: The patient had sour tinge in mouth immediately and tingling arms or fingers following vaccination. The patient was asking if should receive second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Arm hurts; swollen; red; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 2021BI01001415 . A 57 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as unk unk, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Arm hurts"; VACCINATION SITE SWELLING (non-serious), outcome "unknown", described as "swollen"; VACCINATION SITE ERYTHEMA (non-serious), outcome "unknown", described as "red".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: I started feeling achy and fatigued; I started feeling achy and fatigued; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Mar2021 09:30 (Lot number: EN6208) at the age of 55 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "degenerated discs L4-L5, L5-S-1" (unspecified if ongoing); "neuropathy (feet)" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "depression" (unspecified if ongoing); "Benign prostatic hyperplasia" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing). Concomitant medication(s) included: ALFUZOSIN; ATORVASTATIN; BUPROPION; CLOMIPHENE CITRATE. Past drug history included: Amoxicillin, reaction(s): "known allergies: amoxicillin"; Penicillin, reaction(s): "known allergies: Penicillin". The following information was reported: PAIN (non-serious), FATIGUE (non-serious), outcome "unknown" and all described as "I started feeling achy and fatigued".  Additional information- Similar to first dose, I started feeling achy and fatigued, around 48 hours after receiving second dose On the 4th day, I had a small rash or irritation inside right armpit. That spread to my chest by day 5 and I suspected shingles. On day 6 I had a video appt with a doctor who confirmed shingles and prescribed Valtrax, which I took twice daily for 7 days.  The condition worsened and became more painful, and I developed migraine like symptoms for several days. Today is day 23 of feeling these ill effects, I have some improvement but am still not up to working or physical activity. The patient had no Covid prior vaccination. The patient did not had Covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Myalgia, Skin discolouration
Clinical narrative: walking issue appeared; bad muscle aches near his groin; arm became very discolored; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 21Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization. The following information was reported: GAIT DISTURBANCE (non-serious) with onset Apr2021, outcome "unknown", described as "walking issue appeared"; MYALGIA (non-serious) with onset Apr2021, outcome "unknown", described as "bad muscle aches near his groin"; SKIN DISCOLOURATION (non-serious) with onset Apr2021, outcome "unknown", described as "arm became very discolored".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.